Form 4: Chemours Co Director Cowan Reports Acquisition and Disposal of Common Stock

Director Alister Cowan reports changes in beneficial ownership of Chemours Co stock, including acquisition of 14,096 shares and disposal of an unspecified amount.

Summary

• On April 22, 2025, Alister Cowan, a director of Chemours Co, reported transactions involving the company's common stock.
• Cowan acquired 14,096 shares of common stock.
• Cowan also disposed of an unspecified amount of common stock.
• Following these transactions, Cowan beneficially owns 35,830.7011 shares of Chemours Co.
• Cowan has granted a Power of Attorney to Kristine Wellman and Eric Stein to execute and file Forms 3, 4, and 5 on his behalf.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These filings are monitored by investors for insights into management's perspective on the company's stock.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• It helps stakeholders understand the alignment of interests between management and shareholders.

Key Dates

Keywords

Form 4, Chemours Co, Beneficial Ownership, Alister Cowan, Director, Stock Transaction, SEC Filing